These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32200055)

  • 1. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study-An invited commentary.
    Shen G; Mei Z
    Int J Surg; 2020 May; 77():38-39. PubMed ID: 32200055
    [No Abstract]   [Full Text] [Related]  

  • 2. An invited commentary on "risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy".
    Saha S; Mohta A
    Int J Surg; 2020 May; 77():63. PubMed ID: 32200057
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary on: Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
    Roy G; Roy P
    Int J Surg; 2020 May; 77():59-60. PubMed ID: 32200056
    [No Abstract]   [Full Text] [Related]  

  • 4. "Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control".
    Talati JJ
    Int J Surg; 2020 May; 77():96. PubMed ID: 32200061
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
    Jiang Y; Yao Z; Zhu X; Wu B; Bai S
    Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Yamashita S; Ito A; Mitsuzuka K; Tochigi T; Namima T; Soma F; Aizawa M; Ioritani N; Kaiho Y; Arai Y
    Int J Urol; 2016 May; 23(5):378-84. PubMed ID: 26780531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy.
    Fujita K; Ujike T; Nagahara A; Uemura M; Tanigawa G; Shimazu K; Fushimi H; Yamaguchi S; Nonomura N
    Int J Urol; 2015 May; 22(5):463-7. PubMed ID: 25631522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Conditional Survival with Time of Intravesical Recurrence of Upper Tract Urothelial Carcinoma.
    Shigeta K; Kikuchi E; Hagiwara M; Ando T; Mizuno R; Abe T; Mikami S; Miyajima A; Nakagawa K; Oya M
    J Urol; 2017 Dec; 198(6):1278-1285. PubMed ID: 28634017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial Comment to Impact of post-void residual urine volume on intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Hatakeyama S; Ohyama C
    Int J Urol; 2019 Dec; 26(12):1112-1113. PubMed ID: 31522463
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical significance of preoperative renal function and gross hematuria for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
    Hashimoto T; Nakashima J; Kashima T; Hirasawa Y; Shimodaira K; Gondo T; Nakagami Y; Namiki K; Horiguchi Y; Ohno Y; Ohori M; Tachibana M
    Int J Urol; 2017 Feb; 24(2):111-116. PubMed ID: 27875859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal Ureter.
    Seisen T; Nison L; Remzi M; Klatte T; Mathieu R; Lucca I; Bozzini G; Capitanio U; Novara G; Cussenot O; Compérat E; Renard-Penna R; Peyronnet B; Merseburger AS; Fritsche HM; Hora M; Shariat SF; Colin P; Rouprêt M
    J Urol; 2016 May; 195(5):1354-1361. PubMed ID: 26612196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of bladder recurrence after radical nephroureterectomy in upper urinary tract cancer].
    Kovács PT; Juhász D; Módos O; Kocsmár I; Terebessy A; Lotz G; Szarvas T; Nyirády P; Riesz P
    Orv Hetil; 2020 May; 161(21):881-888. PubMed ID: 32427573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: a propensity score-matched multicenter study.
    Fukushima H; Saito K; Ishioka J; Matsuoka Y; Numao N; Koga F; Masuda H; Fujii Y; Sakai Y; Arisawa C; Okuno T; Yonese J; Kamata S; Nagahama K; Noro A; Morimoto S; Tsujii T; Kitahara S; Gotoh S; Higashi Y; Kihara K
    Int J Urol; 2014 Nov; 21(11):1098-104. PubMed ID: 25041040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors for Intravesical Recurrence Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A National Multicenter Analysis.
    Lee CH; Ku JY; Jeong CW; Ku JH; Kwak C; Kim HH; Tae BS; Choi SH; Kim HT; Kim TH; Kwon TG; Hwang EC; Jung SI; Kang TW; Kwon DD; Ha HK
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1055-e1061. PubMed ID: 28802888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An invited commentary on "Assessing the impact of different distal ureter management techniques during radical nephroureterectomy for primary upper urinary tract urothelial carcinoma on oncological outcomes: A systematic review and meta-analysis" [Int. J. Surg. 2020; Epub ahead of print].
    Bakshi GK
    Int J Surg; 2020 Apr; 76():5-6. PubMed ID: 32070731
    [No Abstract]   [Full Text] [Related]  

  • 16. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS
    Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different prediction tools for the risk of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a propensity-matched analysis.
    Luo Z; Jiao B; Zhao H; Huang T; Liu Y; Chen H; Guan Y; Zhang G; Jiang Z
    Clin Transl Oncol; 2024 Jan; 26(1):136-146. PubMed ID: 37273148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UroVysion
    Iwata H; Sassa N; Kato M; Murase Y; Seko S; Kawanishi H; Hattori R; Gotoh M; Tsuzuki T
    Int J Clin Oncol; 2021 Jan; 26(1):178-185. PubMed ID: 32959230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial Comment to Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy.
    Zhang Z; Zhou F
    Int J Urol; 2015 May; 22(5):467-8. PubMed ID: 25808233
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Miyake M; Tatsumi Y; Matsumoto H; Nagao K; Matsuyama H; Inamoto T; Azuma H; Yasumoto H; Shiina H; Fujimoto K;
    BJU Int; 2018 May; 121(5):764-773. PubMed ID: 29281857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.